CareDx: Clinical Trials

30 trials sponsored by CareDx, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

12 completed, 5 unknown, 4 active not recruiting, 4 terminated. 6 Not applicable, 3 Phase 4.

By phase and status

PhaseTrialsStatus
Not applicable6Not yet recruiting 2, Completed 1, Recruiting 1, Terminated 1, Withdrawn 1
Phase 43Completed 2, Active not recruiting 1

Follow CareDx: new trials by email

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Molecular Evidence of Rejection Intervention Trial
Prednisone, Placebo - Heart Transplant Rejection
Not applicableNot yet recruitingCareDx2002027-03-012026-10-29
Forecasting Relapse Outcomes With AlloHeme-based Risk Detection in Post-Allo-HCT AML/MDS Patients (FORWARD)
AlloHeme - AML (Acute Myelogenous Leukemia), MDS (Myelodysplastic Syndrome)
Enrolling by invitationCareDx4002026-09-242026-10-16
Prospective Reduction Of Transplant Complications Through Enhanced Preservation Therapy to Prevent Primary Graft Dysfunction
Xo Port Organ Preservation System, Standard of Care - Ice packs - Primary Graft Dysfunction
Not applicableRecruitingUniversity Health Network, Toronto502026-04-172026-07-13
HeartCare Immuno-optimization in Cardiac Allografts (MOSAIC)
HeartCare - Heart Transplant, Immunosuppression
Not applicableNot yet recruitingCareDx9302025-12-012024-10-23
KidneyCare Immuno-optimization in Renal Allografts (KIRA)
KidneyCare, steroid, MMF - Kidney Transplant, Immunosuppression
Not applicableWithdrawnCareDx2022-08-012023-03-27
AlloSure Lung Assessment and Metagenomics Outcomes Study
Lung Transplant Infection, Lung Transplant; Complications
Active not recruitingCareDx5502021-10-292026-06-25
Technology Enabled And Molecular Monitoring of the Allograft and Transplant rEcipient
Transplant
TerminatedCareDx2462021-10-262023-08-30
Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients
Reduction in antimetabolite immunosuppression - COVID-19, Immunosuppression
Phase 4Active not recruitingUniversity of California, Davis142021-09-242026-04-03
Use of DNA Testing to Help Transition Kidney Transplant Recipients to Belatacept-only Immunosuppression
Belatacept - Kidney Transplant Immunosuppression
Phase 4CompletedUniversity of Texas Southwestern Medical Center252021-07-282026-08-14
Assessment of Chimerism and Relapse Post Bone Marrow/Hematopoietic Cell Transplant (HCT) Using AlloHeme Test
Acute Myeloid Leukemia, Acute Lymphoblastic Leukemia
CompletedCareDx3072021-07-222026-10-16
Assessing Benchmarks For Allosure And Allomap Testing in Simultaneous Kidney & Pancreas Transplant Recipients.
Allosure, AlloMap - Transplant; Complication, Rejection
CompletedMontefiore Medical Center412021-07-142026-07-06
Molecular Assessment and Profiling of Liver Transplant Recipients
LiverCare - Liver Transplantation, Biomarkers
Active not recruitingCareDx15002021-05-262026-09-03
Allosure in Simultaneous Pancreas Kidney Transplant
DD-cfDNA - Kidney Pancreas Transplant
TerminatedWashington University School of Medicine132021-02-262024-08-07
Transition of Renal Patients Using AlloSure Into Community Kidney Care
AlloSure - Kidney Transplant Rejection
CompletedCareDx2482020-11-192023-11-03
The Integration of a Mobile App Platform With Biomarkers in Kidney Transplantation
Smartphone App, Tailored education - Medication Compliance
Not applicableCompletedDuke University222020-10-152022-02-17
Personalization of Immunosuppressive Treatment for Organ Transplant Recipients
AlloSure, PAXGene - Kidney Injury, Kidney Failure
TerminatedGeorge Washington University1052020-10-012024-02-26
Assessment of Donor Derived Cell Free DNA and Utility in Lung Transplantation
Allosure - Lung Transplant Failure and Rejection
Not applicableTerminatedPablo Sanchez402020-06-292024-03-25
AlloSure Guided Immuno-Optimization for COVID-19: An Early Experience
Solid Organ Transplant Rejection, COVID-19
UnknownCareDx5002020-04-012020-04-10
Longitudinal Study of Cell Free DNA in Lung Transplant
Lung Transplant Rejection
CompletedUniversity of Colorado, Denver242020-03-192022-11-02
Immune Monitoring to Facilitate Belatacept Monotherapy
Allosure, Immunosuppression reduction, Trugraf - Kidney Transplant Rejection, Immunosuppression
Phase 4CompletedMassachusetts General Hospital172020-02-112023-12-04

Showing 20 of 30. Sign in to see all of them.

Conditions studied

Rejection, Psychology (4)  ·  COVID-19 (2)  ·  Heart Diseases (2)  ·  Leukemia, Myeloid, Acute (2)  ·  Renal Insufficiency, Chronic (2)  ·  Acute Kidney Injury (1)  ·  Anemia, Refractory, with Excess of Blasts (1)  ·  Kidney Diseases (1)  ·  Kidney Failure, Chronic (1)  ·  Medication Adherence (1)  ·  Myelodysplastic Syndromes (1)  ·  Precursor Cell Lymphoblastic Leukemia-Lymphoma (1)  ·  Primary Graft Dysfunction (1)  ·  Recurrence (1)  ·  Renal Insufficiency (1)

Interventions

Abatacept (2)  ·  Prednisone (2)  ·  Standard of Care (2)  ·  Everolimus (1)  ·  Mycophenolic Acid (1)  ·  Sirolimus (1)  ·  Steroids (1)

Countries

United States (23)  ·  Canada (2)

Top investigators

Kiran Khush, MD (2)  ·  Alice L Gray, MD (1)  ·  Ciara Shaver (1)  ·  Cyrus Feizpour, MD (1)  ·  David Wojciechowski, DO (1)  ·  Debbie Levine (1)  ·  Eileen Chambers, MD (1)  ·  Enver Akalin, MD (1)  ·  Hannah Gilligan, MD (1)  ·  James P Yee (1)  ·  James P Yee, MD, PhD (1)  ·  James Yee, MD (1)  ·  Kanish Mohib, PhD (1)  ·  Nir Uriel, MD, MSc, FACC (1)  ·  Nishant Dwivedi, MD/PhD (1)

Results publications

PMID 33636851, PMID 34184326, PMID 37382155, PMID 41123513, PMID 42302101

NIH funding

K23DK122136 (1)